Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 160 participants.

Also called NCT05955326

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05955326
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
India (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05955326. Randomized; quadruple masking; primary purpose treatment. Start 2024-01-08 (actual); primary completion 2026-12-18 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Condition
Acute Cerebral Ischemia
Intervention (Drug)
Sovateltide
Intervention (Other)
Normal Saline
Lead sponsor
Pharmazz, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05955326
Content hash
9cefeb3650f1b3f5ce010cd0e1494a880c0a36f18e71e36c8f43955d6c96b4be